Print

RisVac02 boost

Safety and Immunological Response of a Boosting Dose of MVA-B in Healthy Volunteers After 4 Years of Receiving MVA-B

Trial Details:

I Scheduled
Hospital Clinic of Barcelona August 14, 2013
MVA-B Gag, Pol, Nef B
MVA-B Viral Vector - Pox
Spain 24
NCT01923610
http://www.clinicaltrials.gov/ct2/show/NCT01923610?term=hiv+and+vaccine&lup_s=08%2F11%2F2013&lup_d=14&show_rss=Y&sel_rss=mod14